No takes yet. Share an insight, caveat, or question.
Randomized trial analyzes hospital survival in STEMI-CS based on MCS availability, indicating no difference in outcomes.
Scholz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: